The future of apolipoprotein E mimetic peptides in the preve... : Current Opinion in
Lipidology The future of apolipoprotein E mimetic peptides in the prevention of …

Atherosclerosis is a chronic inflammatory disorder that occurs as a result of mononuclear
lymphocyte infiltration to the arterial wall, smooth muscle cell proliferation and damage in the …

Nanotechnology has ignited a transformative revolution in disease detection, prevention,
management, and treatment. Central to this paradigm shift is the innovative realm of cell …

Background High density lipoproteins (HDL) contain paraoxonase-1 (PON-1), which has
strong anti-oxidative properties. Apolipoprotein E (apoE) may enhance PON-1 activity in …

Background Our objective was to find single nucleotide polymorphisms (SNPs), within
transcriptional pathways of glucose and lipid metabolism, which are related to multiple …

Liver X receptors (LXRs) are ligand-dependent transcription factors that are activated by
metabolites of cholesterol, oxysterols, and a number of synthetic agonists. LXRs play potent …

Evolvement and progression of cardiovascular diseases affecting the venous and arterial
system are influenced bya multitude of environmental and hereditary factors. Many of these …

Apolipoprotein E (ApoE), a critical targeting protein, has been found to play an essential role
in the protection against infection and inflammation. However, the immune functions of ApoE …

BACKGROUND: We tested the hypothesis that apolipoprotein E (apo E) gene expression
and protein concentration are increased in resectable non-small cell lung cancer tissue and …

Objective—To identify early changes in vascular gene expression mediated by CD44 that
promote atherosclerotic disease in apolipoprotein E (apoE)–deficient (apoE−/−) mice …